Report Detail
Global Lancing Devices for Self-Monitoring of Blood Glucose Market Growth 2022-2028
- RnM4484346 |
- 22 August, 2022 |
- Global |
- 109 Pages |
- LPI(LP Information) |
- Medical Devices & Consumables
Lancing device is an instrument equipped with a lancet. It is also most commonly used by diabetics during blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for fetal scalp blood testing to get a measure of the acid base status of the fetus.
The global market for Lancing Devices for Self-Monitoring of Blood Glucose is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Lancing Devices for Self-Monitoring of Blood Glucose market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Lancing Devices for Self-Monitoring of Blood Glucose market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Lancing Devices for Self-Monitoring of Blood Glucose market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Lancing Devices for Self-Monitoring of Blood Glucose market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Lancing Devices for Self-Monitoring of Blood Glucose players cover Roche, Lifescan, Abbott, Ascensia and B. Braun, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Lancing Devices for Self-Monitoring of Blood Glucose market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Lancing Devices for Self-Monitoring of Blood Glucose market, with both quantitative and qualitative data, to help readers understand how the Lancing Devices for Self-Monitoring of Blood Glucose market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.
Market Segmentation:
The study segments the Lancing Devices for Self-Monitoring of Blood Glucose market and forecasts the market size by Type (Adjustable Lancing Device and Non-adjustable Lancing Device,), by Application (Online and Offline.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Adjustable Lancing Device
Non-adjustable Lancing Device
Segmentation by application
Online
Offline
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
GMMC Group
BIONIME
LIANFA
Lobeck Medical AG
Chapter Introduction
Chapter 1: Scope of Lancing Devices for Self-Monitoring of Blood Glucose, Research Methodology, etc.
Chapter 2: Executive Summary, global Lancing Devices for Self-Monitoring of Blood Glucose market size (sales and revenue) and CAGR, Lancing Devices for Self-Monitoring of Blood Glucose market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Lancing Devices for Self-Monitoring of Blood Glucose sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Lancing Devices for Self-Monitoring of Blood Glucose sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Lancing Devices for Self-Monitoring of Blood Glucose market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY and GMMC Group, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Lancing Devices for Self-Monitoring of Blood Glucose by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Lancing Devices for Self-Monitoring of Blood Glucose by Country/Region, 2017, 2022 & 2028
- 2.2 Lancing Devices for Self-Monitoring of Blood Glucose Segment by Type
- 2.2.1 Adjustable Lancing Device
- 2.2.2 Non-adjustable Lancing Device
- 2.3 Lancing Devices for Self-Monitoring of Blood Glucose Sales by Type
- 2.3.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Type (2017-2022)
- 2.3.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Sale Price by Type (2017-2022)
- 2.4 Lancing Devices for Self-Monitoring of Blood Glucose Segment by Application
- 2.4.1 Online
- 2.4.2 Offline
- 2.5 Lancing Devices for Self-Monitoring of Blood Glucose Sales by Application
- 2.5.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Sale Market Share by Application (2017-2022)
- 2.5.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Sale Price by Application (2017-2022)
3 Global Lancing Devices for Self-Monitoring of Blood Glucose by Company
- 3.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Breakdown Data by Company
- 3.1.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Annual Sales by Company (2020-2022)
- 3.1.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Company (2020-2022)
- 3.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Annual Revenue by Company (2020-2022)
- 3.2.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Company (2020-2022)
- 3.2.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Company (2020-2022)
- 3.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Sale Price by Company
- 3.4 Key Manufacturers Lancing Devices for Self-Monitoring of Blood Glucose Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Lancing Devices for Self-Monitoring of Blood Glucose Product Location Distribution
- 3.4.2 Players Lancing Devices for Self-Monitoring of Blood Glucose Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lancing Devices for Self-Monitoring of Blood Glucose by Geographic Region
- 4.1 World Historic Lancing Devices for Self-Monitoring of Blood Glucose Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Annual Revenue by Geographic Region
- 4.2 World Historic Lancing Devices for Self-Monitoring of Blood Glucose Market Size by Country/Region (2017-2022)
- 4.2.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Annual Revenue by Country/Region
- 4.3 Americas Lancing Devices for Self-Monitoring of Blood Glucose Sales Growth
- 4.4 APAC Lancing Devices for Self-Monitoring of Blood Glucose Sales Growth
- 4.5 Europe Lancing Devices for Self-Monitoring of Blood Glucose Sales Growth
- 4.6 Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Sales Growth
5 Americas
- 5.1 Americas Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country
- 5.1.1 Americas Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2017-2022)
- 5.1.2 Americas Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2017-2022)
- 5.2 Americas Lancing Devices for Self-Monitoring of Blood Glucose Sales by Type
- 5.3 Americas Lancing Devices for Self-Monitoring of Blood Glucose Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Lancing Devices for Self-Monitoring of Blood Glucose Sales by Region
- 6.1.1 APAC Lancing Devices for Self-Monitoring of Blood Glucose Sales by Region (2017-2022)
- 6.1.2 APAC Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Region (2017-2022)
- 6.2 APAC Lancing Devices for Self-Monitoring of Blood Glucose Sales by Type
- 6.3 APAC Lancing Devices for Self-Monitoring of Blood Glucose Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Lancing Devices for Self-Monitoring of Blood Glucose by Country
- 7.1.1 Europe Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2017-2022)
- 7.1.2 Europe Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2017-2022)
- 7.2 Europe Lancing Devices for Self-Monitoring of Blood Glucose Sales by Type
- 7.3 Europe Lancing Devices for Self-Monitoring of Blood Glucose Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose by Country
- 8.1.1 Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Sales by Type
- 8.3 Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Lancing Devices for Self-Monitoring of Blood Glucose
- 10.3 Manufacturing Process Analysis of Lancing Devices for Self-Monitoring of Blood Glucose
- 10.4 Industry Chain Structure of Lancing Devices for Self-Monitoring of Blood Glucose
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Lancing Devices for Self-Monitoring of Blood Glucose Distributors
- 11.3 Lancing Devices for Self-Monitoring of Blood Glucose Customer
12 World Forecast Review for Lancing Devices for Self-Monitoring of Blood Glucose by Geographic Region
- 12.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Market Size Forecast by Region
- 12.1.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Forecast by Region (2023-2028)
- 12.1.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Lancing Devices for Self-Monitoring of Blood Glucose Forecast by Type
- 12.7 Global Lancing Devices for Self-Monitoring of Blood Glucose Forecast by Application
13 Key Players Analysis
- 13.1 Roche
- 13.1.1 Roche Company Information
- 13.1.2 Roche Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.1.3 Roche Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Roche Main Business Overview
- 13.1.5 Roche Latest Developments
- 13.2 Lifescan
- 13.2.1 Lifescan Company Information
- 13.2.2 Lifescan Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.2.3 Lifescan Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Lifescan Main Business Overview
- 13.2.5 Lifescan Latest Developments
- 13.3 Abbott
- 13.3.1 Abbott Company Information
- 13.3.2 Abbott Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.3.3 Abbott Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Abbott Main Business Overview
- 13.3.5 Abbott Latest Developments
- 13.4 Ascensia
- 13.4.1 Ascensia Company Information
- 13.4.2 Ascensia Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.4.3 Ascensia Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Ascensia Main Business Overview
- 13.4.5 Ascensia Latest Developments
- 13.5 B. Braun
- 13.5.1 B. Braun Company Information
- 13.5.2 B. Braun Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.5.3 B. Braun Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 B. Braun Main Business Overview
- 13.5.5 B. Braun Latest Developments
- 13.6 TERUMO
- 13.6.1 TERUMO Company Information
- 13.6.2 TERUMO Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.6.3 TERUMO Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 TERUMO Main Business Overview
- 13.6.5 TERUMO Latest Developments
- 13.7 Sinocare
- 13.7.1 Sinocare Company Information
- 13.7.2 Sinocare Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.7.3 Sinocare Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Sinocare Main Business Overview
- 13.7.5 Sinocare Latest Developments
- 13.8 ARKRAY
- 13.8.1 ARKRAY Company Information
- 13.8.2 ARKRAY Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.8.3 ARKRAY Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 ARKRAY Main Business Overview
- 13.8.5 ARKRAY Latest Developments
- 13.9 GMMC Group
- 13.9.1 GMMC Group Company Information
- 13.9.2 GMMC Group Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.9.3 GMMC Group Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 GMMC Group Main Business Overview
- 13.9.5 GMMC Group Latest Developments
- 13.10 BIONIME
- 13.10.1 BIONIME Company Information
- 13.10.2 BIONIME Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.10.3 BIONIME Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 BIONIME Main Business Overview
- 13.10.5 BIONIME Latest Developments
- 13.11 LIANFA
- 13.11.1 LIANFA Company Information
- 13.11.2 LIANFA Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.11.3 LIANFA Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.11.4 LIANFA Main Business Overview
- 13.11.5 LIANFA Latest Developments
- 13.12 Lobeck Medical AG
- 13.12.1 Lobeck Medical AG Company Information
- 13.12.2 Lobeck Medical AG Lancing Devices for Self-Monitoring of Blood Glucose Product Offered
- 13.12.3 Lobeck Medical AG Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.12.4 Lobeck Medical AG Main Business Overview
- 13.12.5 Lobeck Medical AG Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Lancing Devices for Self-Monitoring of Blood Glucose. Industry analysis & Market Report on Lancing Devices for Self-Monitoring of Blood Glucose is a syndicated market report, published as Global Lancing Devices for Self-Monitoring of Blood Glucose Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Lancing Devices for Self-Monitoring of Blood Glucose market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
